John is a University academic, his focus is on developing breakthrough therapies, devices and technology to repair, replace, augment and in the future regenerate diseased, infected and damaged tissues in humans and other mammals using material interventions. These will come from an in depth generic first principles approach to understanding and directing the patient’s cellular and molecular mechanisms and responses related to the clinical outcome and efficacy of medical devices, biocompatibility, inflammation and stem cell biology. From a strong long lived research platform, specific applications and knowledge has been applied to and continues to be developed for musculoskeletal tissues specifically cartilage and bone, visceral and vascular tissues. Research has been funded by the European Commission, Research England, Innovate U.K. BBSRC, MRC and EPSRC as well as by Industry. He got his BSc. in 1998, his Ph.D in 1992 and D.Sc. in 2006. He is a full time Professor and research Theme Leader at Nottingham Trent University, leading the theme Medical Technologies and Advanced Materials. He is NTU’s academic lead for their Medical Technologies Innovation Facility (MTIF). The aim is to accelerate pipeline development and deliver healthcare applications across all aspects of medical technologies for human and animal health. A Fellow of the Royal Society of Chemistry and the Chairperson of the committee for the specialist interest group Analytical Biosciences Group